Preformulation
Preformulation is the stage of development during which the physicochemical properties of the drug substance are characterised and established. Knowledge of the relevant physiochemical and biopharmaceutical properties determines the appropriate formulation and delivery method for Pre-Clinical and Phase 1 studies.
Through the creation of synergy between solid state chemistry and formulation development, our experienced scientists have the ability to add great value to your pre-clinical project, while decreasing timelines.
We have continued to strengthen our crystallisation development capabilities by the acquisition of BlazeMetrics process analytical technology, which provides real time In-Process high resolution microscopy, analytics, and spectroscopy in a single probe, thus enabling us to better understand the critical parameters that affect crystallisation and to develop robust, scalable crystallisation processes.